H.C. Wainwright analyst Amit Dayal lowered the firm’s price target on ClearSign (CLIR) to $2 from $6 and keeps a Buy rating on the shares. The ...

H.C. Wainwright lowered the firm’s price target on Transcode Therapeutics (RNAZ) to $10 from $20 and keeps a Buy rating on the shares. The firm ...

During the last three months, 16 analysts shared their evaluations of Neurocrine Biosciences NBIX +1.72% Get Free Report , revealing diverse outlooks from bullish to bearish. The following table ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $17.08, a high estimate of ...

Richtech Robotics ( NASDAQ: RR) rallied in late Friday morning trading after H.C. Wainwright initiated coverage on the stock with a Buy rating.

Fintel reports that on April 11, 2025, HC Wainwright & Co. initiated coverage of Richtech Robotics (NasdaqCM:RR) with a Buy ...

Fintel reports that on April 10, 2025, HC Wainwright & Co. downgraded their outlook for Tempest Therapeutics (NasdaqCM:TPST) ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for shares of Alnylam ...

Equities researchers at HC Wainwright lowered their FY2025 EPS estimates for Draganfly in a report issued on Thursday, April 3rd. HC Wainwright analyst S. Buck now anticipates that the company will ...